Study of Aspirin in Patients With Vestibular Schwannoma

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Vestibular Schwannoma, Acoustic Neuroma, Neurofibromatosis 2

In brief

This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.

Key facts

Study ID
NCT03079999
Run by
Massachusetts Eye and Ear Infirmary
People needed
97
Starts
2018-06-11
Expected to finish
2029-02-01
Last updated by the study team
2025-12-18

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.